ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JOHN MITCHELL M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,448Medicare Part D Prescriptions Filled, Including Refills

Rank: 358 out of 1000

$301K Total Retail Price of All Prescriptions

Rank: 452 out of 1000

480 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 480 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 5,053 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 411 276 1 3
LISINOPRIL 303 237 2 5
METOPROLOL TARTRATE 253 154 3 19
OMEPRAZOLE 251 170 4 2
FUROSEMIDE 251 186 4 7
METFORMIN HCL 211 160 6 8
AMLODIPINE BESYLATE 189 147 7 6
CARVEDILOL 186 134 8 15
HYDROCODONE-ACETAMINOPHEN 168 108 S3 9 1
TRAMADOL HCL 153 93 10 13
HYDROCHLOROTHIAZIDE 141 76 11 9
LEVOTHYROXINE SODIUM 133 82 12 4
PRAVASTATIN SODIUM 118 58 13 12
MELOXICAM 113 62 14 14
GABAPENTIN 100 54 15 11
GLIMEPIRIDE 94 84 16 34
HYDRALAZINE HCL 86 73 17 74
POTASSIUM CHLORIDE 84 64 18 10
KLOR-CON M20 82 49 19 66
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 52 20 20
METOPROLOL SUCCINATE 78 50 21 21
CLONIDINE HCL 73 50 22 27
AMLODIPINE BESYLATE-BENAZEPRIL 72 46 23 59
CLOPIDOGREL 71 46 24 35
DIOVAN HCT 71 51 24 96
DIOVAN 69 36 26 67
PLAVIX 61 53 27 49
LOSARTAN POTASSIUM 59 30 28 25
ATORVASTATIN CALCIUM 59 39 28 18
CRESTOR 58 42 30 30
GLIPIZIDE 56 50 31 62
ZOLPIDEM TARTRATE 56 39 31 16
WARFARIN SODIUM 55 52 33 22
METFORMIN HCL ER 55 42 33 44
ENALAPRIL MALEATE 54 38 35 58
SERTRALINE HCL 53 40 36 26
CITALOPRAM HBR 52 33 37 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.